Claudio MereuJoint Managing Partner at Field Fisher
Claudio Mereu is a partner in Fieldfisher's Brussels office and head up the firms Competition, Regulatory and Trade group and life sciences group.
His expertise focuses on European Union law, with an emphasis on the chemicals (REACH), pesticides, biocides and life sciences industry sectors, as well as other regulated industries including medical devices, pharmaceuticals, cosmetics, toys, electrical and electronic equipment, and fuel additives (including devising lobbying strategies and general compliance issues).
He handles product approval processes in the EU, related litigation before European courts, national courts and WTO panels, and counsels companies on a wide range of business law and antitrust matters relating to their international agreements and commercial presence in Europe.
His expertise covers all aspects of product regulations and restrictions (including notification, data protection, mutual recognition, classification & labelling, marketing and use restrictions, parallel imports, environmental liability, product recalls and data compensation negotiations, amongst others).
He advises life sciences clients on the importation, regulation and sale of medical devices, pharmaceuticals, GMOs, novel food, food supplements and food contact materials.
He represents chemical companies before the European Institutions, Member State authorities, Scientific Committees, and the European Courts. I was involved in the first case of data sharing arbitration in Italy and in a case of alleged abuse of dominant position on pesticides markets, both of which he successfully resolved.
He regularly speaks at international conferences as an expert speaker and panellist on pesticides and chemicals and am highly recommended by Legal 500 where clients quote "Claudio Mereu “gets results”, and appreciate his “very efficient and positive” approach to cases, Chambers Europe where clients say “Claudio Mereu understands the business and tries to bridge the gap between business needs and legal requirements” and the Life Sciences Industry Report.
He is fluent in English, French, Spanish and Italian.